...
首页> 外文期刊>Psychosomatics >Reduced Anxiety and Depression in Patients With Advanced Heart Failure After Left Ventricular Assist Device Implantation
【24h】

Reduced Anxiety and Depression in Patients With Advanced Heart Failure After Left Ventricular Assist Device Implantation

机译:左心室辅助装置植入后晚期心力衰竭患者减少焦虑和抑郁症

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Despite the high prevalence of depression and anxiety in patients with advanced heart failure, the effects of left ventricular assist device (LVAD) implantation on these critically important aspects of mental health are not well understood. Objective: We sought to assess changes in depression and anxiety following LVAD implantation. Methods: The Beck Depression Inventory-II (BDI-II) and Beck Anxiety Inventory (BAI) were administered to 54 patients by a clinical psychologist at a mean of 12 days before LVAD implantation and 251 days after implantation. Patient demographics and clinical data were collected concurrently to psychologic testing. Changes in BDI-II, BAI, and clinical markers of heart failure were assessed using paired t-tests. A p < 0.05 was considered significant. Results: The average age of the group was 56.63 years with a mean ejection fraction 20.8%. Before implantation, mean BAI and BDI scores indicated mild depression and anxiety. Following LVAD implantation, average scores for both BDI-II and BAI decreased significantly, indicating minimal depression and anxiety (12.6-8.54, p = 0.001 and 12.06-6.6, p < 0.001, respectively). Mean scores were significantly lowered in 11 and 8 of the 21 subdomains tested by the BAI and BDI, respectively. Significant improvements were noted in post-LVAD B-type natriuretic peptide, serum sodium, and blood urea nitrogen. Conclusion: Depression and anxiety scores improved significantly after LVAD implantation. Factors contributing to changes in depression and anxiety after LVAD could be related to the improvement in acute heart failure sy.mptoms, functional capacity, and quality of life. Prospective studies with larger sample sizes are warranted.
机译:背景:尽管晚期心力衰竭患者抑郁和焦虑的患病率很高,但左心室辅助装置(LVAD)植入对这些至关重要的心理健康方面的影响尚不清楚。目的:我们试图评估LVAD植入后抑郁和焦虑的变化。方法:临床心理学家在LVAD植入前平均12天和植入后平均251天对54名患者进行贝克抑郁量表II(BDI-II)和贝克焦虑量表(BAI)测试。在心理测试的同时收集患者的人口统计学和临床数据。使用配对t检验评估BDI-II、BAI和心力衰竭临床标志物的变化。p<0.05被认为是显著的。结果:该组患者的平均年龄为56.63岁,平均射血分数为20.8%。植入前,平均BAI和BDI评分显示轻度抑郁和焦虑。LVAD植入后,BDI-II和BAI的平均得分显著降低,表明抑郁和焦虑程度最低(分别为12.6-8.54,p=0.001和12.06-6.6,p<0.001)。在BAI和BDI分别测试的21个子域中,有11个和8个子域的平均分显著降低。LVAD后B型利钠肽、血清钠和血尿素氮显著改善。结论:LVAD植入后抑郁和焦虑评分显著改善。导致LVAD后抑郁和焦虑改变的因素可能与急性心力衰竭的改善有关。MPTOM、功能能力和生活质量。大样本量的前瞻性研究是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号